Cardiac troponin-I on diagnosis predicts early death and refractoriness in acquired thrombotic thrombocytopenic purpura. Experience of the French Thrombotic Microangiopathies Reference Center.
about
Twice-daily therapeutical plasma exchange-based salvage therapy in severe autoimmune thrombotic thrombocytopenic purpura: the French TMA Reference Center experience.Bortezomib in the treatment of refractory thrombotic thrombocytopenic purpura.Assessment of endothelial damage and cardiac injury in a mouse model mimicking thrombotic thrombocytopenic purpura.Thrombotic thrombocytopenic purpura presenting as acute coronary syndrome.Increased troponin I is associated with fatal outcome in acquired thrombotic thrombocytopenic purpura.Thrombotic Thrombocytopenic Purpura in Black People: Impact of Ethnicity on Survival and Genetic Risk FactorsThe role of hemovigilance and postmarketing studies when introducing innovation into transfusion medicine practice: the amotosalen-ultraviolet A pathogen reduction treatment model.Caplacizumab reduces the frequency of major thromboembolic events, exacerbations and death in patients with acquired thrombotic thrombocytopenic purpura.Recent advances in understanding and management of acquired thrombocytopenia.Myocardial Infarction as an Early Presentation in Thrombotic Thrombocytopenic Purpura: A Rare Case Series.Thrombotic thrombocytopenic purpuraThrombotic thrombocytopenic purpura associated with dengue and chikungunya virus coinfection: case report during an epidemic period
P2860
Q33427885-69E77874-CD2F-4AC8-9C1D-445295A87D88Q33430998-93A6BDB8-8CEA-4820-BBF6-87E147120975Q33434431-A1CD81D6-22D3-421B-9580-EFDA2652D908Q33434645-15F0F64E-1359-463D-B628-1A4B8DE3D850Q33435833-643365E4-C947-455B-AAF3-6D967C0C2DDDQ36068855-4DCDF4DC-2BD3-4CDB-A5F7-EC2528E5E620Q38784176-E449D7B7-AD14-48C0-8EC8-FD2D193B82F0Q38818496-8F8729C7-477B-47E9-AC52-4C0AFA81CECBQ48109292-2BAE8C1B-ADEE-4073-A047-E07A04F29917Q54998968-5E11EC29-89EE-4B0B-959D-21A073C5FDD8Q57379903-5217577A-65FA-49C1-88A4-FE89F1568C1FQ58742196-A5CAC717-02EB-4DFB-9471-1498145444CE
P2860
Cardiac troponin-I on diagnosis predicts early death and refractoriness in acquired thrombotic thrombocytopenic purpura. Experience of the French Thrombotic Microangiopathies Reference Center.
description
2014 nî lūn-bûn
@nan
2014 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Cardiac troponin-I on diagnosi ...... angiopathies Reference Center.
@ast
Cardiac troponin-I on diagnosi ...... angiopathies Reference Center.
@en
type
label
Cardiac troponin-I on diagnosi ...... angiopathies Reference Center.
@ast
Cardiac troponin-I on diagnosi ...... angiopathies Reference Center.
@en
prefLabel
Cardiac troponin-I on diagnosi ...... angiopathies Reference Center.
@ast
Cardiac troponin-I on diagnosi ...... angiopathies Reference Center.
@en
P2093
P2860
P356
P1476
Cardiac troponin-I on diagnosi ...... angiopathies Reference Center.
@en
P2093
A Veyradier
D Bordessoule
P2860
P304
P356
10.1111/JTH.12790
P577
2014-12-18T00:00:00Z